skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 22  for All Library Resources

Results 1 2 next page
Refined by: Database: RePEc remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal
Material Type:
Article
Add to My Research

Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal

PharmacoEconomics, 2011-12, Vol.29 (12), p.1051-1062 [Peer Reviewed Journal]

Springer International Publishing AG 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11591600-000000000-00000 ;PMID: 21967156

Full text available

2
Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
Material Type:
Article
Add to My Research

Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review

PharmacoEconomics, 2012, Vol.30 (1), p.17-34 [Peer Reviewed Journal]

Adis Data Information BV 2012 ;2015 INIST-CNRS ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11595000-000000000-00000 ;PMID: 22201521

Full text available

3
Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence
Material Type:
Article
Add to My Research

Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence

PharmacoEconomics, 2011-05, Vol.29 (5), p.415-432 [Peer Reviewed Journal]

Adis Data Information BV 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Springer ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11588340-000000000-00000 ;PMID: 21504241

Full text available

4
Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?
Material Type:
Article
Add to My Research

Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?

PharmacoEconomics, 2010-06, Vol.28 (6), p.463-475 [Peer Reviewed Journal]

Adis Data Information BV 2010 ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;COPYRIGHT 2010 Springer ;Copyright Wolters Kluwer Health Adis International Jun 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11533000-000000000-00000 ;PMID: 20465315

Full text available

5
Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation
Material Type:
Article
Add to My Research

Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation

PharmacoEconomics, 2010, Vol.28 (1), p.35-46 [Peer Reviewed Journal]

Adis Data Information BV 2010 ;COPYRIGHT 2010 Springer ;Copyright Wolters Kluwer Health Adis International Jan 2010 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11314070-000000000-00000 ;PMID: 20014875

Full text available

6
Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses A Decision Tree Model: A Decision Tree Model
Material Type:
Article
Add to My Research

Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses A Decision Tree Model: A Decision Tree Model

PharmacoEconomics, 2010-11, Vol.28 (11), p.1055-1064 [Peer Reviewed Journal]

Adis Data Information BV 2010 ;2015 INIST-CNRS ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;COPYRIGHT 2010 Springer ;Copyright Wolters Kluwer Health Adis International Nov 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11538670-000000000-00000 ;PMID: 20936887

Full text available

7
Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma
Material Type:
Article
Add to My Research

Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma

PharmacoEconomics, 2012-05, Vol.30 (5), p.413-429 [Peer Reviewed Journal]

Springer International Publishing AG 2012 ;2015 INIST-CNRS ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11591540-000000000-00000 ;PMID: 22428718

Full text available

8
Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures
Material Type:
Article
Add to My Research

Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures

PharmacoEconomics, 2012-01, Vol.30 (7), p.565-573 [Peer Reviewed Journal]

Springer International Publishing AG 2012 ;2015 INIST-CNRS ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11588320-000000000-00000 ;PMID: 22686661

Full text available

9
Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making Internationally
Material Type:
Article
Add to My Research

Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making Internationally

PharmacoEconomics, 2010-01, Vol.28 (5), p.347-349 [Peer Reviewed Journal]

Adis Data Information BV 2010 ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International May 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11535680-000000000-00000 ;PMID: 20402539

Full text available

10
Advances in Cancer Therapeutics and Patient Access to New Drugs
Material Type:
Article
Add to My Research

Advances in Cancer Therapeutics and Patient Access to New Drugs

PharmacoEconomics, 2011-03, Vol.29 (3), p.213-224 [Peer Reviewed Journal]

Springer International Publishing AG 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;COPYRIGHT 2011 Springer ;Copyright Wolters Kluwer Health Adis International Mar 2011 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11584210-000000000-00000 ;PMID: 21184619

Full text available

11
Cost Effectiveness of Rituximab for Non-Hodgkin’s Lymphoma: A Systematic Review
Material Type:
Article
Add to My Research

Cost Effectiveness of Rituximab for Non-Hodgkin’s Lymphoma: A Systematic Review

PharmacoEconomics, 2012-07, Vol.30 (7), p.537-549 [Peer Reviewed Journal]

Springer International Publishing AG 2012 ;2015 INIST-CNRS ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11591160-000000000-00000 ;PMID: 22612993

Full text available

12
Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer
Material Type:
Article
Add to My Research

Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer

PharmacoEconomics, 2011-10, Vol.29 (10), p.827-837 [Peer Reviewed Journal]

Adis Data Information BV 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11585940-000000000-00000 ;PMID: 21770482

Full text available

13
Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer: A Critical and Systematic Review
Material Type:
Article
Add to My Research

Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer: A Critical and Systematic Review

PharmacoEconomics, 2010-01, Vol.28 (8), p.629-647 [Peer Reviewed Journal]

Adis Data Information BV 2010 ;2015 INIST-CNRS ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International Aug 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11535560-000000000-00000 ;PMID: 20524722

Full text available

14
Economic Burden of Follicular Non-Hodgkin’s Lymphoma
Material Type:
Article
Add to My Research

Economic Burden of Follicular Non-Hodgkin’s Lymphoma

PharmacoEconomics, 2009-01, Vol.27 (8), p.657-679 [Peer Reviewed Journal]

Adis Data Information BV 2009 ;2009 INIST-CNRS ;Copyright Wolters Kluwer Health Adis International Aug 2009 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11314820-000000000-00000 ;PMID: 19712009

Full text available

15
Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach
Material Type:
Article
Add to My Research

Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach

Health economics, 2008-01, Vol.17 (1), p.67-81 [Peer Reviewed Journal]

Copyright © 2007 John Wiley & Sons, Ltd. ;Copyright (c) 2007 John Wiley & Sons, Ltd. ;Copyright Wiley Periodicals Inc. Jan 2008 ;ISSN: 1057-9230 ;EISSN: 1099-1050 ;DOI: 10.1002/hec.1243 ;PMID: 17533622 ;CODEN: HEECEZ

Full text available

16
Adjuvant Trastuzumab for Breast Cancer: Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA Trial
Material Type:
Article
Add to My Research

Adjuvant Trastuzumab for Breast Cancer: Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA Trial

PharmacoEconomics, 2011-05, Vol.29 (5), p.361-365 [Peer Reviewed Journal]

Adis Data Information BV 2011 ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11588350-000000000-00000 ;PMID: 21504237

Full text available

17
Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer
Material Type:
Article
Add to My Research

Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer

PharmacoEconomics, 2008-01, Vol.26 (8), p.699-719 [Peer Reviewed Journal]

Adis Data Information BV 2008 ;2008 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826080-00006 ;PMID: 18620462

Full text available

18
Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis
Material Type:
Article
Add to My Research

Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis

PharmacoEconomics, 2008, Vol.26 (1), p.33-44 [Peer Reviewed Journal]

Adis Data Information BV 2008 ;2008 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826010-00004 ;PMID: 18088157

Full text available

19
The economics of the NHS cancer drugs fund
Material Type:
Article
Add to My Research

The economics of the NHS cancer drugs fund

Applied health economics and health policy, 2011-05, Vol.9 (3), p.137-138 [Peer Reviewed Journal]

Adis Data Information BV 2011 ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International May 2011 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.2165/11585750-000000000-00000 ;PMID: 21506619

Full text available

20
Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE Clinical trial
Material Type:
Article
Add to My Research

Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE Clinical trial

Applied health economics and health policy, 2011-09, Vol.9 (5), p.305-315 [Peer Reviewed Journal]

Adis Data Information BV 2011 ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International Sep 2011 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.2165/11592200-000000000-00000 ;PMID: 21875161

Full text available

Results 1 - 20 of 22  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1999  (1)
  2. 1999 To 2000  (1)
  3. 2001 To 2007  (1)
  4. 2008 To 2009  (4)
  5. After 2009  (16)
  6. More options open sub menu

Searching Remote Databases, Please Wait